alexa The Effect Of Antimicrobial Agents On Shiga-toxin 2 Release In Escherichia Coli O104:H4 And Role Of The SOS Response
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Congress on Bacteriology & Infectious Diseases
November 17-19, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Ghassan M Matar
ScientificTracks Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.006
Abstract
The effect of different regimens of rifampicin and gentamicin were evaluated to determine possible treatment modes for the novel Escherichia coli O104:H4 pathotype and evaluate the effects of the SOS response on Shiga-toxin 2 (Stx2) release. Pulsed field gel electrophoresis (PFGE) was performed on the novel E. coli O104:H4 pathotype and two pre-outbreak E. coli O104:H4 CDC strains. Transcription levels of the stx2 and recA gene (SOS response inducer) were evaluated by RTqPCR using different regimens of rifampicin and gentamicin. Reverse passive latex agglutination (RPLA) determined the Stx2 titers in these samples. Western blotting detected the LexA levels (SOS response repressor). The efficacy of treatment with antimicrobial agents was assessed in BALB/c mice. PFGE analysis showed that the outbreak and pre-outbreak strains are genomically closely related. The transcription level of the stx2 gene in the new pathotype was 1.41 and 1.75 fold that of the 2 pre-outbreak strains respectively. Different combinations of the antimicrobial agents? concentrations led to a significant reduction in the transcription level of the stx2 gene. RPLA data were in accordance with the RT-qPCR results. E. coli O104:H4 exposed to gentamicin led to high transcription levels of the recA gene and lack of expression of the LexA protein, implying activation of the SOS response. In vivo, the highest survival rate in BALB/c mice was observed with treatment by MBC of gentamicin. In conclusion, the use of antimicrobial agents in E. coli O104:H4 infection seems to be effective. This provides a promising ground for treatment of E. coli O104:H4 infections.
Biography
Ghassan M Matar is currently a Professor in the Department of Experimental Pathology, Immunology & Microbiology and Laboratory Director of the Center for Infectious Diseases Research at the Faculty of Medicine, American University of Beirut (AUB). He received his PhD in Basic Medical Sciences (Microbiology) from AUB and was a Post-doctoral Fellow (Fulbright) at the Centers for Disease Control Prevention (CDC) and Department of Microbiology and Immunology, Emory University in Atlanta, Georgia, USA. He was then appointed as Research Microbiologist at the Division of Bacterial and Mycotic Diseases, CDC. He was also appointed as Assistant Dean at the Faculty of Health Science, AUB. In addition, he currently serves in WHO as advisor in the Advisory Group on Integrated Surveillance of Antimicrobial Agents (AGISAR), and as American Society for Microbiology (ASM) Ambassador to Lebanon. His Laboratory is a PulseNet Laboratory certified by CDC. He has published 90 articles in peer reviewed international journals and presented 115 papers in international, regional and local conferences. He received funding from various extramural sources such as: CDC, U.S. Department of Defense (DOD), WHO/AGISAR, PulseNet (CDC, WHO, MOPH) and others. His research interests include: 1) Molecular mechanisms of resistance to antimicrobial agents in pathogenic bacteria, 2) Potential Treatment of E. coli O157:H7 and O104:H4 infections, 3) Biofilm production in P. aeruginosa and potential inhibition of biofilm formation, 4) Expression levels of virulence factors in bacterial agents in relation to disease production, 5) Molecular epidemiology of foodborne diseases and nosocomial infections.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords